KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Operating Income (2020 - 2025)

Organon has reported Operating Income over the past 6 years, most recently at $210.0 million for Q4 2025.

  • Quarterly results put Operating Income at $210.0 million for Q4 2025, down 27.08% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 72.41% YoY), and the annual figure for FY2025 was $1.1 billion, up 569.23%.
  • Operating Income for Q4 2025 was $210.0 million at Organon, down from $358.0 million in the prior quarter.
  • Over the last five years, Operating Income for OGN hit a ceiling of $411.0 million in Q3 2024 and a floor of -$579.0 million in Q4 2023.
  • Median Operating Income over the past 5 years was -$183.0 million (2021), compared with a mean of -$104.0 million.
  • Biggest five-year swings in Operating Income: crashed 495.08% in 2021 and later skyrocketed 200.0% in 2024.
  • Organon's Operating Income stood at -$363.0 million in 2021, then crashed by 33.06% to -$483.0 million in 2022, then dropped by 19.88% to -$579.0 million in 2023, then soared by 149.74% to $288.0 million in 2024, then fell by 27.08% to $210.0 million in 2025.
  • The last three reported values for Operating Income were $210.0 million (Q4 2025), $358.0 million (Q3 2025), and $324.0 million (Q2 2025) per Business Quant data.